Israel-based venture studio AION Labs has recently unveiled its latest venture, TenAces Biosciences, poised to revolutionize molecular glue discovery through the power of machine learning. The groundbreaking initiative is backed by major pharmaceutical players, including AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund, Amiti Ventures, and Amazon Web Services, in collaboration with Germany’s BioMed X. Transformative